2018
Hocher A et al.
Expanding heterochromatin reveals discrete subtelomeric domains delimited by chromatin landscape transitions
Genome Research 2018 28(12)
doi: 10.1101/gr.236554.118
Jiménez I et al.
Circulating tumor DNA analysis enables molecular characterization of pediatric renal tumors at diagnosis
International Journal of Cancer 2018 144(1)
doi: 10.1002/ijc.31620
Kamal M et al.
Revisited analysis of a SHIVA01 trial cohort using functional mutational analyses successfully predicted treatment outcome
Molecular Oncology 2018 12(5)
doi: 10.1002/1878-0261.12180
Liang X et al.
Molecular profiling of hormone receptor-positive, HER2-negative breast cancers from patients treated with neoadjuvant endocrine therapy in the CARMINA 02 trial (UCBG-0609)
J Hematol Oncology 2018 11(1)
doi: 10.1186/s13045-018-0670-9
Liang X et al.
Targeted next-generation sequencing identifies clinically relevant somatic mutations in a large cohort of inflammatory breast cancer
Breast Cancer Research 2018 20(1)
doi: 10.1186/s13058-018-1007-x
Lopez-Delisle L et al.
Activated ALK signals through the ERKETV5RET pathway to drive neuroblastoma oncogenesis
Oncogene 2018 37(11)
doi: 10.1038/s41388-017-0039-5
Machiela MJ et al.
Genome-wide association study identifies multiple new loci associated with Ewing sarcoma susceptibility
Nat Commun. 2018 9(1)
doi: 10.1038/s41467-018-05537-2
Marangoni E et al.
Capecitabine Efficacy Is Correlated with TYMP and RB1 Expression in PDX Established from Triple-Negative Breast Cancers
Clinical Cancer Research 2018 24(11)
doi: 10.1158/1078-0432.CCR-17-3490
Melloni GEM et al.
Precision Trial Drawer, a Computational Tool to Assist Planning of Genomics-Driven Trials in Oncology
JCO Precision Oncology 2018 2
doi: 10.1200/PO.18.00015
Michea P et al.
Adjustment of dendritic cells to the breast-cancer microenvironment is subset specific
Nature Immunology 2018 19(8
doi: 10.1038/s41590-018-0145-8